Literature DB >> 4532629

Biologic activity of some adriamycin (NSC-123127) derivatives.

L Lenaz, A Necco, T Dasdia, A Di Marco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4532629

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  4 in total

Review 1.  New cancer chemotherapy drugs in Europe.

Authors:  G Mathé; L M van Putten
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

2.  Uptake and distribution of daunorubicin and daunorubicin-DNA complex in mice as studied by whole-body autoradiography and liquid chromatography.

Authors:  B Andersson; M Beran; B Eberhardsson; S Eksborg; P Slanina
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  Adriamycin and daunomycin dose-dependent effects upon contractions of isolated rat myocytes.

Authors:  M C Lowe; J I Smallwood
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma.

Authors:  Masafumi Yamashita; Hiroshi Wada; Hidetoshi Eguchi; Hisataka Ogawa; Daisaku Yamada; Takehiro Noda; Tadafumi Asaoka; Koichi Kawamoto; Kunihito Gotoh; Koji Umeshita; Yuichiro Doki; Masaki Mori
Journal:  Int J Oncol       Date:  2016-04-25       Impact factor: 5.650
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.